Search Within

Michael Nishimura

Refine Results
Formats
  1. Journal Article (42)
Groups
  1. Cardinal Bernardin Cancer Center (42)
  2. Oncology Research Institute (42)
  3. Infectious Disease and Immunology Research Institute (8)
People
  1. Swati Mehrotra (8)
  2. Isabelle Caroline LePoole (7)
  3. Makio Iwashima (6)
  4. Tamson Moore (6)
  5. Constantine Godellas (3)
  6. Jiwang Zhang (3)

More People

Years
  1. 2022 (2)
  2. 2021 (3)
  3. 2020 (3)
  4. 2019 (2)
  5. 2018 (7)
  6. 2017 (7)

More Years

Journals
  1. Cancer immunology, immunotherapy : CII (6)
  2. Cancer research (5)
  3. Immunology (2)
  4. Journal of leukocyte biology (2)
  5. Molecular therapy oncolytics (2)
  6. Oncotarget (2)

More Journals

Publishers
  1. American Association for Cancer Research (4)
  2. Elsevier Inc (3)
  3. Wiley Periodicals, Inc (2)
  4. AACR (1)
  5. European Federation of Immunological Societies. Published by Elsevier B.V (1)
  6. by The American Association of Immunologists, Inc (1)

Results (42)

  • Siglec-5 is an inhibitory immune checkpoint molecule for human T cells.
    Journal Article

    Vuchkovska, A; Glanville, DG; Scurti, GM; Nishimura, MI; White, P; Ulijasz, AT; Iwashima, M
    Immunology (2022)

    Find It @ Loyola | Save
  • Genetic Modification of T Cells for the Immunotherapy of Cancer.
    Journal Article

    Quinn, S; Lenart, N; Dronzek, V; Scurti, GM; Hossain, NM; Nishimura, MI
    Vaccines (2022)

    Find It @ Loyola | Save
  • Human CD36 monocytes induce Foxp3 CD25 T cells with regulatory functions from CD4 and CD8 subsets.
    Journal Article

    Lee, JG; Jaeger, KE; Seki, Y; Lim, YW; Cunha, C; Vuchkovska, A; Nelson, AJ; Nikolai, A; Kim, D; Nishimura, M; more...
    Immunology (2021)

    Find It @ Loyola | Save
  • HDAC inhibition prevents transgene expression downregulation and loss-of-function in T-cell-receptor-transduced T cells.
    Journal Article

    Moore, TV; Scurti, GM; DeJong, M; Wang, SY; Dalheim, AV; Wagner, CR; Hutchens, KA; Speiser, JJ; Godellas, CV; Fountain, C; more...
    Molecular therapy oncolytics (2021)

    Find It @ Loyola | Save
  • Melanoma reactive TCR-modified T cells generated without activation retain a less differentiated phenotype and mediate a superior in vivo response.
    Journal Article

    Wang, SY; Moore, TV; Dalheim, AV; Scurti, GM; Nishimura, MI
    Scientific reports (2021)

    Find It @ Loyola | Save
  • Endothelin-1-mediated Drug Resistance in EGFR-mutant NSCLC.
    Journal Article

    Pulido, I; Ollosi, S; Aparisi, S; Becker, JH; Aliena-Valero, A; Benet, M; Rodríguez, ML; López, A; Tamayo-Torres, E; Chuliá-Peris, L; more...
    Cancer research (2020)

    Find It @ Loyola | Save
  • Improved MHC II epitope prediction - a step towards personalized medicine.
    Journal Article

    Moore, TV; Nishimura, MI
    Nature reviews. Clinical oncology (2020)

    Find It @ Loyola | Save
  • Identification of human CD4 T cell populations with distinct antitumor activity.
    Journal Article

    Nelson, MH; Knochelmann, HM; Bailey, SR; Huff, LW; Bowers, JS; Majchrzak-Kuligowska, K; Wyatt, MM; Rubinstein, MP; Mehrotra, S; Nishimura, MI; more...
    Science advances (2020)

    Find It @ Loyola | Save
  • Potassium channel activity controls breast cancer metastasis by affecting ß-catenin signaling.
    Journal Article

    Breuer, EK; Fukushiro-Lopes, D; Dalheim, A; Burnette, M; Zartman, J; Kaja, S.; Wells, C; Campo, L; Curtis, KJ; Romero-Moreno, R; more...
    Cell death disease (2019)

    Find It @ Loyola | Save
  • Late Events After CD-19 CAR-T Treatment.
    Journal Article

    Hossain, NM; Nishimura, MI
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation (2019)

    Find It @ Loyola | Save